University of Calgary/UCEED


Zymedyne is one company #UCalgary’s UCeed is pursuing investments in. Its technology works at the molecular level to prevent the body from undergoing certain changes that cause chronic pain, helping a broad range of patients. Learn more:

Posted by University of Calgary

Campus alberta neuroscience

SmartCompany Magazine

SmartCompany Magazine article highlights MQ incubator’s Zymedyne Therapeutics:


Health and economy at the forefront of Macquarie University Incubator’s 2023 startup cohort


Past News